| AstraZeneca PLC | 852.40 / -0.33% |
| Date/Time | 04/12 / 17:24 |
| Chg. / Chg.(%) | -2.80 / -0.33% |
| Bid | 851.60 / 90 |
| Ask | 874.00 / 12 |
| Open | 852.60 |
| Previous Close | 855.20 |
| High | 863.70 |
| Low | 848.40 |
| Volume [SEK] | 116,579,890.35 |
| Volume [Units] | 379,302 |
| Price fixings | 4811 |
| ISIN | GB0009895292 |
| Security | AZN/S |
| Exchange | Cboe Europe DXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| London Domes.. | 7,225.0 |  |
1,497,166 |
| OMX Nordic | 852.30 | |
959,490 |
| Cboe Europe .. | 852.40 | |
379,302 |
| Cboe Europe .. | 7,229.00 | |
334,516 |
| Cboe Europe .. | 7,225.00 | |
205,531 |
| Turquoise | 7,230.00 | |
135,448 |
| Turquoise | 852.30 | |
49,251 |
| Xetra | 83.41 | |
27,651 |
| TradeGate | 83.620 | |
12,927 |
| Frankfurt | 83.1500 | |
2,525 |
| Cboe Europe .. | 858.60 | |
2,454 |
| Nasdaq Other.. | 99.3200 |  |
1,226 |
| Stuttgart | 82.710 | |
655 |
| gettex | 83.620 | |
437 |
| Cboe Europe .. | 850.45 | |
416 |
| Berlin | 83.13 | |
136 |
| Düsseldorf | 83.50 | |
80 |
| München | 83.43 | |
80 |
| Hannover | 84.00 | |
0 |
| Hamburg | 84.00 | |
0 |
| Lang & Schwa.. | 83.150 | |
|
| ICE Europe | Futures | ||
| EUREX | Options | ||
News
- Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
04/12/2021 / 14:30 - GlobeNewswire - NMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who Failed Platinum-Containing Chemotherapy or Progressed within 12 Months of Neoadjuvant or Adjuvant Platinum-Containing Chemotherapy
04/12/2021 / 14:00 - GlobeNewswire - S. Korean biotech firms planning phase 3 vaccine trials
04/12/2021 / 12:02 - TeleTrader - AstraZeneca cuts vaccine deliveries to EU by half - report
04/09/2021 / 18:05 - TeleTrader - WHO has no data on mixing different vaccines
04/09/2021 / 15:51 - TeleTrader
Real-time